NFE2L2 and breast carcinoma: Elevated NRF2 enhanced the growth and motility of breast cancer cells by upregulating a pivotal enzyme of the pentose phosphate pathway, i.e., the glucose-6-phosphate dehydrogenase (G6PD) (195).